Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 12/20 | 1.00 |
| ▸ | CNR2 | P34972 | 5/20 | 1.00 |
| ▸ | KDR | P35968 | 3/20 | 0.81 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Delta-8-Tetrahydrocannabinol SCHEMBL29360992 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL31545578 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL120839 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL31545313 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL31315116 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL2800340 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL12054803 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL2762327 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL31236168 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR | |
| Delta-8-Tetrahydrocannabinol SCHEMBL29361531 | 1.00 | CNR1 (1.00) | CNR1CNR2KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220031781-A1 | CANNABIS OIL EXTRACTS AND COMPOSITIONS | CONSTANCE THERAPEUTICS, INC. (US) | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220031781-A1 | CANNABIS OIL EXTRACTS AND COMPOSITIONS | CNR2, CNR1, DNER | CNR1 2/4885CNR2 1/4885KDR 1088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.